Abstract
Objective
To highlight the MRI characteristics of pathologically proven amyloidosis involving the peripheral nervous system (PNS) and determine the utility of MRI in directing targeted biopsy for aiding diagnosis.
Materials and methods
A retrospective study was performed for patients with pathologically proven PNS amyloidosis who also underwent MRI of the biopsied or excised nerve. MRI signal characteristics, nerve morphology, associated muscular denervation changes, and the presence of multifocal involvement were detailed. Pathology reports were reviewed to determine subtypes of amyloid. Charts were reviewed to gather patient demographics, neurological symptoms and radiologist interpretation.
Results
Four men and three women with a mean age of 62 ± 11 years (range 46–76) were identified. All patients had abnormal findings on EMG with mixed sensorimotor neuropathy. All lesions demonstrated diffuse multifocal neural involvement with T1 hypointensity, T2 hyperintensity, and variable enhancement on MRI. One lesion exhibited superimposed T2 hypointensity. Six of seven patients demonstrated associated muscular denervation changes.
Conclusion
Peripheral nerve amyloidosis is rare, and the diagnosis is difficult because of insidious symptom onset, mixed sensorimotor neurologic deficits, and the potential for a wide variety of nerves affected. On MRI, peripheral nerve involvement is most commonly characterized by T1 hypointensity, T2 hyperintensity, variable enhancement, maintenance of the fascicular architecture with fusiform enlargement, multifocal involvement and muscular denervation changes. While this appearance mimics other inflammatory neuropathies, MRI can readily detect neural changes and direct-targeted biopsy, thus facilitating early diagnosis and appropriate management.
Similar content being viewed by others
References
Sipe JD, Benson MD, Buxbaum JN, Ikeda S, Merlini G, Saraiva MJ, et al. Nomenclature 2014: amyloid fibril proteins and clinical classification of the amyloidosis. Amyloid. 2014;21(4):221–4.
Consales A, Roncaroli F, Salvi F, Poppi M. Amyloidoma of the brachial plexus. Surg Neurol. 2003;59(5):418–23. discussion 423.
Ladha SS, Dyck PJ, Spinner RJ, Perez DG, Zeldenrust SR, Amrami KK, et al. Isolated amyloidosis presenting with lumbosacral radiculoplexopathy: description of two cases and pathogenic review. J Peripher Nerv Syst. 2006;11(4):346–52.
Shin SC, Robinson-Papp J. Amyloid neuropathies. Mt Sinai J Med. 2012;79(6):733–48.
Loavenbruck AJ, Chaudhry V, Zeldenrust SR, Spinner RJ, Theis JD, Klein CJ. Mass spectrometry analysis reveals non-mutated apolipoprotein A1 lumbosacral radiculoplexus amyloidoma. Muscle Nerve. 2012;46(5):817–22.
Tracy JA, Dyck PJ, Dyck PJB. Primary amyloidosis presenting as upper limb multiple mononeuropathies. Muscle Nerve. 2010;41(5):710–5.
Real de Asua D, Costa R, Galvan JM, Filigheddu MT, Trujillo D, Cadinanos J. Systemic AA amyloidosis: epidemiology, diagnosis, and management. Clin Epidemiol. 2014;6:369–77.
Duston MA, Skinner M, Meenan RF, Cohen AS. Sensitivity, specificity, and predictive value of abdominal fat aspiration for the diagnosis of amyloidosis. Arthritis Rheum. 1989;32(1):82–5.
Duston MA, Skinner M, Shirahama T, Cohen AS. Diagnosis of amyloidosis by abdominal fat aspiration: analysis of four years’ experience. Am J Med. 1987;82(3):412–4.
Libbey CA, Skinner M, Cohen AS. Use of abdominal fat tissue aspirate in the diagnosis of systemic amyloidosis. Arch Intern Med. 1983;143(8):1549–52.
Hachulla E, Grateau G. Diagnostic tools for amyloidosis. Joint Bone Spine. 2002;69(6):538–45.
Thawait SK, Chaudhry V, Thawait GK, Wang KC, Belzberg A, Carrino JA, et al. High-resolution MR neurography of diffuse peripheral nerve lesions. AJNR Am J Neuroradiol. 2011;32(8):1365–72.
Laeng RH, Altermatt HJ, Scheithauer BW, Zimmermann DR. Amyloidomas of the nervous system: a monoclonal B-cell disorder with monotypic amyloid light chain lambda amyloid production. Cancer. 1998;82(2):362–74.
Haridas A, Basu S, King A, Pollock J. Primary isolated amyloidoma of the lumbar spine causing neurological compromise: case report and literature review. Neurosurgery. 2005;57(1):E196.
Gottfried ON, Chin S, Davidson HC, Couldwell WT. Trigeminal amyloidoma: case report and review of the literature. Skull Base. 2007;17(5):317–24.
Bornemann A, Bohl J, Hey O, Storkel S, Gamm H, Muller-Forell W, et al. Amyloidoma of the gasserian ganglion as a cause of symptomatic neuralgia of the trigeminal nerve: report of three cases. J Neurol. 1993;241(1):10–4.
Kanta M, Ehler E, Kohout A, Habalova J, Hanacek R, Vysata O, et al. Rare case of a localized radial nerve amyloid neuropathy. J Clin Neuromuscul Dis. 2014;16(1):20–3.
Pizov G, Soffer D. Amyloid tumor (amyloidoma) of a peripheral nerve. Arch Pathol Lab Med. 1986;110(10):969–70.
Kyle RA. Amyloidosis. Clin Haematol. 1982;11(1):151–80.
Gabet JY, Vital Durand D, Bady B, Kopp N, Sindou M, Levrat R. Amyloid pseudotumor of the sciatic nerve. Rev Neurol (Paris). 1989;145(12):872–6.
O’Brien TJ, McKelvie PA, Vrodos N. Bilateral trigeminal amyloidoma: an unusual case of trigeminal neuropathy with a review of the literature. Case report. J Neurosurg. 1994;81(5):780–3.
Ahlawat S, Chhabra A, Blakely J. Magnetic resonance neurography of peripheral nerve tumors and tumorlike conditions. Neuroimaging Clin N Am. 2014;24(1):171–92.
Porchet F, Sonntag VK, Vrodos N. Cervical amyloidoma of C2. Case report and review of the literature. Spine (Phila Pa 1976). 1998;23(1):133–8.
Unal A, Sutlap PN, Kyyyk M. Primary solitary amyloidoma of thoracic spine: a case report and review of the literature. Clin Neurol Neurosurg. 2003;105(3):167–9.
Gandhi D, Wee R, Goyal M. CT and MR imaging of intracerebral amyloidoma: case report and review of the literature. AJNR Am J Neuroradiol. 2003;24(3):519–22.
Matsumoto T, Tani E, Fukami M, Kaba K, Yokota M, Hoshii Y. Amyloidoma in the gasserian ganglion: case report. Surg Neurol. 1999;52(6):600–3.
Dember LM. Amyloidosis-associated kidney disease. J Am Soc Nephrol. 2006;17(12):3458–71.
Gertz MA, Buadi FK, Hayman SR. Treatment of immunoglobulin light chain (primary or AL) amyloidosis. Oncology (Williston Park). 2011;25(7):620–6.
Oh SJ. Diagnostic usefulness and limitations of the sural nerve biopsy. Yonsei Med J. 1990;31(1):1–26.
Dyck PJB, Spinner R, Amrami KK, Klein CJ, Engelstad JK, Dyck PJ. MRI-targeted fascicular nerve biopsies of proximal nerves: historic reports and illustrative case reports. 2010th ed. Philadelphia: Saunders Elsevier; 2010.
Ruth A, Schulmeyer FJ, Roesch M, Woertgen C, Brawanski A. Diagnostic and therapeutic value due to suspected diagnosis, long-term complications, and indication for sural nerve biopsy. Clin Neurol Neurosurg. 2005;107(3):214–7.
Capek S, Amrami KK, Dyck PJB, Spinner RJ. Targeted fascicular biopsy of the sciatic nerve and its major branches: rationale and operative technique. Neurosurg Focus. 2015;39(3).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Disclosure
The authors have nothing to disclose.
Rights and permissions
About this article
Cite this article
McKenzie, G.A., Broski, S.M., Howe, B.M. et al. MRI of pathology-proven peripheral nerve amyloidosis. Skeletal Radiol 46, 65–73 (2017). https://doi.org/10.1007/s00256-016-2510-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00256-016-2510-8